Market Research Report Insights

The global  online grocery market  is anticipated to witness USD 1.1 Trillion by 2027, expanding at a CAGR of 24.8% till 2027, according to a study by Grand View Research, Inc. Growing use of the smartphone and technological penetration in the consumer market is likely to enhance the market growth. In addition, growing scope of E-commerce and shopping sites are emerging as game changers in the consumer market. The popularity of online shopping sites in the global marketspace is gaining a huge traction owing to effective customer service. For instance, contact centers working 24*7*365 are readily available for customer assistance on call. This has added to the brand value of online companies in the B2C space. Simultaneously, online companies are experiencing positive growth in the consumer base Y-O-Y basis.Emergence of AI technology and personal assistant offered by several companies are proving effective in the way of customer service and is also helping in the customer retent...

The global hyperlipidemia drugs market size is expected to reach USD 22.6 billion by 2022, according to a new report by Grand View Research, Inc., expanding at a CAGR of 2.3% during the forecast period. Several factors, such as an increase in target population and growth in awareness about the risk of Cardiovascular Diseases (CVD) due to persistent hypercholesterolemia, are stoking the growth of the market. Hyperlipidemia is the most common type of dyslipidemia and is generally caused by abnormally high lipid levels in the blood. This condition can occur due to genetic factors (primary hyperlipidemia) as well as other factors such as poor diet and unhealthy lifestyle (secondary hyperlipidemia). Statins are the first line of treatment for secondary hyperlipidemia. The target population of antihyperlipidemic drugs is broadly divided into statin users and nonstatin users. The revenue share of statin users has been declining. The nonstatin users segment consists of a statin-intolerant a...

The global biomaterials marke t is anticipated to be worth USD 348.4 billion by 2027, progressing at a significant CAGR of 15.9% during this period, according to a recent report by Grand View Research. The field of biomaterials has been around for more than 50 years, with these substances being tailored to interact with biological systems for therapeutic or diagnostic purposes. Both large as well as small organizations in this space are churning out new products at a healthy pace, thus accounting for positive growth of the biomaterials market. Some of the major advantages that biomaterials offer include biocompatibility, low toxicity and renewability, thus making them ideal drug delivery agents, which is expected to drive market growth for biomaterials. Continued R&D with regards to improving bioactivity, compatibility, and mechanical properties of biomaterials has increased their scope. Moreover, the advent of 3D printing and additive manufacturing is also expected to influence t...

The global biopharmaceutical third party logistics market size is expected to reach USD 120.64 billion by 2025, at a CAGR 4.9% over the forecast period, according to a new report by Grand View Research, Inc. The market for biopharmaceutical third party logistics (3PL) is majorly driven by rising demand for temperature controlled logistic services to transport biologics in various regions and growing distribution networks of biopharmaceutical companies to improve their sales. Rising adoption of automated storage and retrieval systems in the emerging countries is an ongoing trend in the pharmaceutical logistics companies that has gained a significant traction. Furthermore, the trend of shifting from small molecule drugs to biopharmaceuticals, mainly vaccines and biologics, is projected to drive the market. Since, these small molecule drugs are temperature sensitive products, demand for temperature controlled transportation and storage increases and thus is responsible for the market gr...

The global single lead ECG equipment market size is estimated to reach USD 487.59 million by 2025, progressing at a 4.72% CAGR during the forecast period, according to a new report by Grand View Research, Inc. Emergence of smartphone and mobile-based cardiac monitoring devices has been revolutionized the market in the past few years. Medical device manufacturers continue to invest in development of these products in order to overcome pitfalls associated with conventional means of cardiac assessment. This is, consequently, fostering the growth of the market. An Indian company Agatsa Software Pvt. Ltd. introduced credit-card-sized ECG monitors, “Sanket”, which measures ECG in 15 seconds and displays results that can be sent to anyone across the globe via email, social media platforms, or SMS. Such advancements in ECG monitoring devices are anticipated to shape the future of the market over the forecast period. On the other hand, government bodies are undertaking initiatives for impro...

The global pharmaceutical grade lactose market size is expected to reach USD 254.8 million by 2025 at a 4.6% CAGR during the forecast period, according to a new report by Grand View Research, Inc. Rising inclination toward preventive healthcare across the globe is estimated to boost product use over the forecast period. Increasing investments by local and foreign players in the pharmaceutical manufacturing sector, especially in developing economies such as India and Brazil, is expected to have a positive influence on industry growth. Furthermore, increased access to medication through generic drug production and development of innovative treatments for chronic diseases has resulted in the growth of the drug manufacturing industry, thereby propelling product demand. Raw material prices and operational and transportation costs are key factors that define final product price. Intense competition in the industry is expected to put pressure on prices, resulting in a decline in product pr...

The global dlif  & xlif implants market size is anticipated to reach USD 389.9 million by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 8.2% during the forecast period. Increasing prevalence of spinal cord injuries and diseases, growing adoption of minimally invasive surgical procedures, availability of technologically advanced products for spinal surgeries, and increasing obesity are augmenting the market. Aging is one of the critical factors responsible for spine degeneration, which leads to instability and back pain. Thus, rising geriatric population worldwide is projected to increase the demand for DLIF and XLIF implants. These implants are minimally invasive procedures and are gaining popularity owing to their associated advantages such as reduction in duration of surgery and hospital stay, lower trauma and incisions, lower blood loss, reduced recovery time, and reduced damage to surrounding tissues & anatomical structures. DLIF a...